(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3922.75 | 3324.43 | 18.00 | 3922.75 | 3324.43 | 18.00 | 13487.36 | 13117.84 | 2.82 |
| Other Income | 261.04 | 285.55 | -8.58 | 261.04 | 285.55 | -8.58 | 1129.65 | 1241.92 | -9.04 |
| PBIDT | 746.07 | 726.63 | 2.68 | 746.07 | 726.63 | 2.68 | 2104.25 | 2626.91 | -19.90 |
| Interest | 24.76 | 29.11 | -14.94 | 24.76 | 29.11 | -14.94 | 100.38 | 153.09 | -34.43 |
| PBDT | 721.31 | 697.52 | 3.41 | 721.31 | 697.52 | 3.41 | 1938.68 | 2473.82 | -21.63 |
| Depreciation | 127.95 | 102.46 | 24.88 | 127.95 | 102.46 | 24.88 | 455.03 | 395.45 | 15.07 |
| PBT | 593.36 | 595.06 | -0.29 | 593.36 | 595.06 | -0.29 | 1483.65 | 2078.37 | -28.61 |
| TAX | 144.97 | 146.39 | -0.97 | 144.97 | 146.39 | -0.97 | 367.25 | 468.39 | -21.59 |
| Deferred Tax | -8.53 | -15.84 | -46.15 | -8.53 | -15.84 | -46.15 | -3.69 | -7.14 | -48.32 |
| PAT | 448.39 | 448.67 | -0.06 | 448.39 | 448.67 | -0.06 | 1116.40 | 1609.98 | -30.66 |
| Equity | 306.21 | 306.21 | 0.00 | 306.21 | 306.21 | 0.00 | 306.21 | 306.21 | 0.00 |
| PBIDTM(%) | 19.02 | 21.86 | -12.99 | 19.02 | 21.86 | -12.99 | 15.60 | 20.03 | -22.09 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1898.00 |
| Dr. Reddys Labs. | 1171.00 |
| Cipla | 1416.00 |
| Lupin | 2220.00 |
| Zydus Lifesciences | 1105.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: